The Evolving Landscape of Factor Replacement Therapy – EAHAD
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
“Summer is the perfect time to catch up on the educational content you’ve been meaning to watch and stay up to date with the latest developments in haemophilia care.
One topic that continues to evolve rapidly is factor replacement therapy.
As treatment options expand, choosing the most appropriate factor VIII and factor IX replacement products and understanding how monitoring is changing has become increasingly important for delivering personalised care.
In this recorded session, Jan Astermark, Annette Bowyer and Cedric Hermans (Lon,Edin) examine the latest evidence, discuss the expanding therapeutic landscape, and explore how monitoring is evolving to support more precise, individualised treatment decisions.
What session is next on your summer learning list?”
Other posts about European Association for Haemophilia and Allied Disorders on Hemostasis Today.
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?